Boston Scientific Corp. (BSX)
47.80
+0.85
(+1.81%)
USD |
NYSE |
Sep 04, 16:00
47.77
-0.03
(-0.06%)
Pre-Market: 20:00
Boston Scientific Research and Development Expense (Quarterly) : 554.00M for June 30, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 554.00M |
| March 31, 2026 | 516.00M |
| December 31, 2025 | 569.00M |
| September 30, 2025 | 514.00M |
| June 30, 2025 | 526.00M |
| March 31, 2025 | 443.00M |
| December 31, 2024 | 460.00M |
| September 30, 2024 | 407.00M |
| June 30, 2024 | 383.00M |
| March 31, 2024 | 366.00M |
| December 31, 2023 | 363.00M |
| September 30, 2023 | 356.00M |
| June 30, 2023 | 359.00M |
| March 31, 2023 | 337.00M |
| December 31, 2022 | 330.00M |
| September 30, 2022 | 339.00M |
| June 30, 2022 | 335.00M |
| March 31, 2022 | 319.00M |
| December 31, 2021 | 320.00M |
| September 30, 2021 | 310.00M |
| June 30, 2021 | 298.00M |
| March 31, 2021 | 276.00M |
| December 31, 2020 | 286.00M |
| September 30, 2020 | 315.00M |
| June 30, 2020 | 242.00M |
| Date | Value |
|---|---|
| March 31, 2020 | 300.00M |
| December 31, 2019 | 309.00M |
| September 30, 2019 | 306.00M |
| June 30, 2019 | 280.00M |
| March 31, 2019 | 280.00M |
| December 31, 2018 | 288.00M |
| September 30, 2018 | 289.00M |
| June 30, 2018 | 275.00M |
| March 31, 2018 | 261.00M |
| December 31, 2017 | 264.00M |
| September 30, 2017 | 254.00M |
| June 30, 2017 | 244.00M |
| March 31, 2017 | 235.00M |
| December 31, 2016 | 256.00M |
| September 30, 2016 | 232.00M |
| June 30, 2016 | 222.00M |
| March 31, 2016 | 210.00M |
| December 31, 2015 | 244.00M |
| September 30, 2015 | 221.00M |
| June 30, 2015 | 220.00M |
| March 31, 2015 | 192.00M |
| December 31, 2014 | 208.00M |
| September 30, 2014 | 212.00M |
| June 30, 2014 | 206.00M |
| March 31, 2014 | 191.00M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Abbott Laboratories | 892.00M |
| Becton, Dickinson & Co. | 258.00M |
| Penumbra, Inc. | 19.96M |
| Intuitive Surgical, Inc. | 370.40M |
| Stryker Corp. | 424.00M |